Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1981 May;19(5):813–820. doi: 10.1128/aac.19.5.813

Bacteriological aspects of selective decontamination of the digestive tract as a method of infection prevention in granulocytopenic patients.

H G de Vries-Hospers, D T Sleijfer, N H Mulder, D van der Waaij, H O Neiweg, H K van Saene
PMCID: PMC181528  PMID: 7027923

Abstract

We describe the bacteriological results of a controlled clinical trial of selective decontamination of the digestive tract as a method of infection prevention in granulocytopenic patients. Selective elimination of Enterobacteriaceae and Pseudomonadaceae species was accomplished by the oral administration of nalidixic acid, co-trimoxazole, or polymyxin. Yeasts were eliminated selectively by amphotericin B or nystatin treatment. The drugs used in this study were chosen because of their capacities to selectively eliminate gram-negative rods and yeast without affecting the anaerobic part of the gut flora which is responsible for colonization resistance. Compared with the control group, the selectively decontaminated patients had significantly fewer (P less than 0.0005) gram-negative rods or yeasts or both in their throat swab cultures and in their feces. This reduction may explain the clinical effectiveness of selective decontamination.

Full text

PDF
813

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alpern R. J., Dowell V. R., Jr Clostridium septicum infections and malignancy. JAMA. 1969 Jul 21;209(3):385–388. [PubMed] [Google Scholar]
  2. Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
  3. Bodey G. P., Rodriguez V. Infections in cancer patients on a protected environment-prophylactic antibiotic program. Am J Med. 1975 Oct;59(4):497–504. doi: 10.1016/0002-9343(75)90257-0. [DOI] [PubMed] [Google Scholar]
  4. Bodey G. P., Rosenbaum B. Effect of prophylactic measures on the microbial flora of patients in protected environment units. Medicine (Baltimore) 1974 May;53(3):209–228. doi: 10.1097/00005792-197405000-00004. [DOI] [PubMed] [Google Scholar]
  5. Butler D. A., Lobregat C. M., Gavan T. L. Reproducibility of the analytab (API 20E) system. J Clin Microbiol. 1975 Oct;2(4):322–326. doi: 10.1128/jcm.2.4.322-326.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cooke E. M., Kumar P. J., Shooter R. A., Rousseau S. A., Foulkes A. L. Hospital food as a possible source of Escherichia coli in patients. Lancet. 1970 Feb 28;1(7644):436–437. doi: 10.1016/s0140-6736(70)90830-5. [DOI] [PubMed] [Google Scholar]
  7. Dankert J., Gaus W., Gaya H., Krieger D., Linzenmeier G., van der Waaij D. Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection. A prospective cooperative study of gnotobiotic care in acute leukaemia patients. III: The quality of isolation and decontamination. Infection. 1978;6(4):175–191. doi: 10.1007/BF01641908. [DOI] [PubMed] [Google Scholar]
  8. Dietrich M., Gaus W., Vossen J., van der Waaij D., Wendt F. Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection. A prospective cooperative study of gnotobiotic care in acute leukemia patients. I: clinical results. Infection. 1977;5(2):107–114. doi: 10.1007/BF01642091. [DOI] [PubMed] [Google Scholar]
  9. Emmelot C. H., van der Waaij D. The dose at which neomycin and polymyxin B can be applied for selective decontamination of the digestive tract in mice. J Hyg (Lond) 1980 Jun;84(3):331–340. doi: 10.1017/s0022172400026851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Felner J. M., Dowell V. R., Jr "Bacteroides" bacteremia. Am J Med. 1971 Jun;50(6):787–796. doi: 10.1016/0002-9343(71)90187-2. [DOI] [PubMed] [Google Scholar]
  11. Guiot H. F., Furth R. Partial antibiotic decontamination. Br Med J. 1977 Mar 26;1(6064):800–802. doi: 10.1136/bmj.1.6064.798-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hahn D. M., Schimpff S. C., Fortner C. L., Smyth A. C., Young V. M., Wiernik P. H. Infection in acute leukemia patients receiving oral nonabsorable antibiotics. Antimicrob Agents Chemother. 1978 Jun;13(6):958–964. doi: 10.1128/aac.13.6.958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Klastersky J., Debusscher L., Weerts D., Daneau D. Use of oral antibiotics in protected units environment: clinical effectiveness and role in the emergence of antibiotic-resistant strains. Pathol Biol (Paris) 1974 Jan;22(1):5–12. [PubMed] [Google Scholar]
  14. Klastersky J., Hensgens C., Debusscher L. Protected environment and intestinal decontamination in acute leukemia. Acta Clin Belg. 1975;30(4):327–332. doi: 10.1080/17843286.1975.11717017. [DOI] [PubMed] [Google Scholar]
  15. Koopman J. P., Janssen F. G., van Druten J. A. The relation between the intestinal microflora and intestinal parameters in mice. Z Versuchstierkd. 1977;19(1-2):54–61. [PubMed] [Google Scholar]
  16. Koransky J. R., Stargel M. D., Dowell V. R., Jr Clostridium septicum bacteremia. Its clinical significance. Am J Med. 1979 Jan;66(1):63–66. doi: 10.1016/0002-9343(79)90483-2. [DOI] [PubMed] [Google Scholar]
  17. Krick J. A., Remington J. S. Opportunistic invasive fungal infections in patients with leukaemia lymphoma. Clin Haematol. 1976 Jun;5(2):249–310. [PubMed] [Google Scholar]
  18. Levine A. S., Siegel S. E., Schreiber A. D., Hauser J., Preisler H., Goldstein I. M., Seidler F., Simon R., Perry S., Bennett J. E. Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia. N Engl J Med. 1973 Mar 8;288(10):477–483. doi: 10.1056/NEJM197303082881001. [DOI] [PubMed] [Google Scholar]
  19. Murray P. R. Standardization of the Analytab Enteric (API 20E) system to increase accuracy and reproducibility of the test for biotype characterization of bacteria. J Clin Microbiol. 1978 Jul;8(1):46–49. doi: 10.1128/jcm.8.1.46-49.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Rodriguez V., Bodey G. P., Freireich E. J., McCredie K. B., Gutterman J. U., Keating M. J., Smith T. L., Gehan E. A. Randomized trial of protected environment--prophylactic antibiotics in 145 adults with acute leukemia. Medicine (Baltimore) 1978 May;57(3):253–266. doi: 10.1097/00005792-197805000-00005. [DOI] [PubMed] [Google Scholar]
  21. Schimpff S. C., Greene W. H., Young V. M., Fortner C. L., Cusack N., Block J. B., Wiernik P. H. Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis. Ann Intern Med. 1975 Mar;82(3):351–358. doi: 10.7326/0003-4819-82-3-351. [DOI] [PubMed] [Google Scholar]
  22. Schimpff S. C., Young V. M., Greene W. H., Vermeulen G. D., Moody M. R., Wiernik P. H. Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens. Ann Intern Med. 1972 Nov;77(5):707–714. doi: 10.7326/0003-4819-77-5-707. [DOI] [PubMed] [Google Scholar]
  23. Shooter R. A., Gaya H., Cooke E. M., Kumar P., Patel N., Parker M. T., Thom B. T., France D. R. Food and medicaments as possible sources of hospital strains of Pseudomonas aeruginosa. Lancet. 1969 Jun 21;1(7608):1227–1229. doi: 10.1016/s0140-6736(69)92114-x. [DOI] [PubMed] [Google Scholar]
  24. Sleijfer D. T., Mulder N. H., de Vries-Hospers H. G., Fidler V., Nieweg H. O., van der Waaij D., van Saene H. K. Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract. Eur J Cancer. 1980 Jun;16(6):859–869. doi: 10.1016/0014-2964(80)90140-1. [DOI] [PubMed] [Google Scholar]
  25. Storring R. A., Jameson B., McElwain T. J., Wiltshaw E. Oral non-absorbed antibiotics prevent infection in acute non-lymphoblastic leukaemia. Lancet. 1977 Oct 22;2(8043):837–840. doi: 10.1016/s0140-6736(77)90779-6. [DOI] [PubMed] [Google Scholar]
  26. Thijm H. A., van der Waaij D. The effect of three frequently applied antibiotics on the colonization resistance of the digestive tract of mice. J Hyg (Lond) 1979 Jun;82(3):397–405. doi: 10.1017/s0022172400053924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Van der Waaij D., Tielemans-Speltie T. M., De Roeck-Houben A. M. Infection by the distribution of biotypes of enterobacteriacease species in leukaemic patients treated under ward conditions and in units for protective isolation in seven hospitals in Europe. Infection. 1977;5(3):188–194. doi: 10.1007/BF01639756. [DOI] [PubMed] [Google Scholar]
  28. Welling G. W., Groen G., Tuinte J. H., Koopman J. P., Kennis H. M. Biochemical effects on germ-free mice of association with several strains of anaerobic bacteria. J Gen Microbiol. 1980 Mar;117(1):57–63. doi: 10.1099/00221287-117-1-57. [DOI] [PubMed] [Google Scholar]
  29. van der Waaij D., Berghuis-de Vries J. M., Lekkerkerk Lekkerkerk-v Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. J Hyg (Lond) 1971 Sep;69(3):405–411. doi: 10.1017/s0022172400021653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. van der Waaij D., Berghuis-de Vries J. M. Selective elimination of Enterobacteriaceae species from the digestive tract in mice and monkeys. J Hyg (Lond) 1974 Apr;72(2):205–211. doi: 10.1017/s002217240002341x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. van der Waaij D., Berghuis J. M. Determination of the colonization resistance of the digestive tract of individual mice. J Hyg (Lond) 1974 Jun;72(3):379–387. doi: 10.1017/s0022172400023615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. van der Waaij D., Berghuis J. M., Lekkerkerk J. E. Colonization resistance of the digestive tract of mice during systemic antibiotic treatment. J Hyg (Lond) 1972 Dec;70(4):605–610. doi: 10.1017/s0022172400022464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. van der Waaij D., Speltie T. M., Vossen J. M. Biotyping of Enterobacteriaceae as a test for the evaluation of isolation systems. J Hyg (Lond) 1972 Dec;70(4):639–650. doi: 10.1017/s0022172400022506. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES